ChemMedChem · 2019 · 15 citations · 23 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryEnzymologyStructure-activity RelationshipsEnzyme InhibitionStructure-activity Relationship AnalysisChemical Structure-activity RelationshipsCompetitive InhibitionEnzyme Inhibitor DiscoveryMycobacterium Tuberculosis InfectionNovel Antibacterial AgentsNovel Antibacterial Drug DiscoveryStructure - Activity Relationship OptimizationThymidylate Synthesis
Since the discovery of a flavin-dependent thymidylate synthase (ThyX or FDTS) that is absent in humans but crucial for DNA biosynthesis in a diverse group of pathogens, the enzyme has been pursued for the development of new antibacterial agents against Mycobacterium tuberculosis, the causative agent of the widespread infectious disease tuberculosis (TB). In response to a growing need for more effective anti-TB drugs, we have built upon our previous screening efforts and report herein an optimization campaign of a novel series of inhibitors with a unique inhibition profile. The inhibitors display competitive inhibition toward the methylene tetrahydrofolate cofactor of ThyX, enabling us to generate a model of the compounds bound to their target, thus offering insight into their structure-activity relationships.
23
CDD/SPARCLE: functional classification of proteins via subfamily domain architectures
Aron Marchler‐Bauer, Bo Yu, Lianyi Han et al. · Nucleic Acids Research · 2016 · 2.9K citations · Full text
A Diarylquinoline Drug Active on the ATP Synthase of <i>Mycobacterium tuberculosis</i>
Koen Andries, Peter Verhasselt, Jérôme Guillemont et al. · Science · 2004 · 2.2K citations · Full text
Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
Maria Tarcela Gler, Vija Skripconoka, Epifanio Sànchez-Garavito et al. · New England Journal of Medicine · 2012 · 737 citations · Full text